~~<i id='F4D60798DC'><strike id='F4D60798DC'><tt id='F4D60798DC'><pre id='F4D60798DC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：comprehensive 2025-10-02 10:45:26 - browse：7462

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

explore

Wikipedia

explore

knowledge

explore

AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

WSS

Artificial intelligence use in health care faces greater scrutiny in 2024

U.S. death rates show how politics are affecting public health

Long Covid research funding gets a major boost from NIH

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

The Bio Revolution is changing business and society

Juul documents reveal insider tactics on political lobbying

knowledge

hotspot

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Guardant Health colon cancer test endorsed by FDA advisory panel

As demand for Covid shots wanes, Moderna seeks its next success

Some medical students still think black patients feel less pain

Tori Bowie and the unacceptable rates of Black maternal death

Decentralized clinical trials need collaboration to achieve wider use

As demand for Covid shots wanes, Moderna seeks its next success

Study gives hint on South Asians’ higher risk of cardiovascular disease

Psychedelics group wrestles with new pharma identity

Stroke rates rising, especially in working

Wikipedia

Should insurance cover cosmetic surgery?

Congress must protect the remaining independent doctors

Why we need mandatory labeling of GMO products

Report cites 'urgent' need to recruit more diverse clinical trial participants

Congress must protect the remaining independent doctors

STAT Boddities: What happens to the brain when we get scared?

Wikipedia

explore

knowledge

explore